IntroductionPlacenta previa and accreta, which occur after a previous cesarean surgery, are linked to serious negative consequences for both the mother and the fetus throughout pregnancy. They also provide a significant risk of maternal mortality [1]. Disseminated intravascular coagulation, shock, and a high rate of hysterectomy can be attributed to these placental abnormalities [2]. Postpartum bleeding is mostly attributed to placenta previa and placenta accreta, which are recognized as significant contributors to maternal mortality on a global scale. The occurrence of significant bleeding during cesarean section (CS), which is difficult to anticipate and manage, poses a substantial risk to the lives of patients with placenta previa and accreta. The cesarean hysterectomy procedure is a significant therapeutic intervention for placenta previa and accreta; yet, it is imperative to use prudence during its execution [3]. Lately, there has been a significant increase in conservative management practices aimed at minimizing intraoperative hemorrhage and reducing the rate of hysterectomy, while also prioritizing the safety of both the mother and newborn after cesarean section. There is a growing utilization of the prophylactic intravascular balloon occlusion approach for the management of uncontrolled hemorrhage in patients with CS. This method involves the proactive use of a balloon to block the blood flow in the internal iliac arteries (PBOIIA) and abdominal aorta arteries (PBOAA) [4].Obstetricians face the challenge of managing fetal death during the second or third trimester in the presence of placenta previa. This is because the abruption of the placenta during labor induction can lead to uncontrollable bleeding, potentially covering the internal organs. Existing literature rarely documents the management of this condition, making it a subject of debate. It is imperative to create strategies aimed at improving antenatal diagnosis. In cases where there is suspicion of an aberrant invasion of pregnant women, it is advisable to refer them to a tertiary facility. This is because the management of maternal adenocarcinoma (MAP) necessitates a multidisciplinary approach and the involvement of an experienced team [5].Here, we present a case study of a woman who underwent two unsuccessful abortions using mifepristone and misoprostol during early pregnancy due to a lack of a birth plan. Additionally, she underwent a failed abortion using levano amniocentesis after being pregnant for over four months. Ultrasound results indicated placental previa and placental implantation. The patient underwent bilateral uterine artery embolisation and bilateral ureteral stenting before having a caesarean section to retrieve the fetus. Due to hemorrhage and hemorrhagic shock, a total hysterectomy was performed before the patient was discharged from the hospital.